SEARCH

SEARCH BY CITATION

References

  • 1
    EngelhardtM,HenßH,BergerDP,MertelsmannR, eds. The blue book 2007/2008,1st edn. Heidelberg, Germany: Springer, 2006. 202 p.
  • 2
    BergerD,EngelhardtR,MertelsmannR, eds. The red book,3rd edn. Landsberg/Lech, Gemany: Ecomed, 2006. 1049 p.
  • 3
    WeisA,HaasP,BauchmüllerK,KühnemundA,KinzelP,LuchtM,ThierryV,EngelhardtM. “Severe adverse event” (SAE) documentation and analysis: a modern feature of good clinical practice (GCP) in cancer treatment. Onkologie 2005; 212: 655.
  • 4
    WeisA,ChevalierN,HaasP,SchröttnerP,KollerA,JestädtA,HeinzJ,HenβH,EngelhardtM. A vision of quality performance in cancer treatment: two years of experience with a reporting system of any severe adverse event (SAE) in treating cancer patients. Onkologie 2006; 222: 896.
  • 5
    WeisA,MüllerAMS,GöbelA,HenβH,EngelhardtM. GCP Freiburg. Krankenhauspharmazie 2006; 27: 1938.
  • 6
    KohnLT. The Institute of Medicine report on medical error: overview and implications for pharmacy. Am J Health Syst Pharm 2001; 58: 636.
  • 7
    BatesDW,SpellN,CullenDJ,BurdickE,LairdN,PetersenLA,SmallSD,SweitzerBJ,LeapeLL. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997; 277: 30711.
  • 8
    SchwabeU,PaffrathD. Arzneiverordnungs-Report 2004 Aktuelle Daten, Kosten, Trends und Kommentare. Springer, 2004
  • 9
    GandhiTK,BartelSB,ShulmanLN,VerrierD,BurdickE,ClearyA,RothschildJM,LeapeLL,BatesDW. Medication safety in the ambulatory chemotherapy setting. Cancer 2005; 104: 247783.
  • 10
    EnerRA,MeglatherySB,StylerM. Extravasation of systemic hemato-oncological therapies. Ann Oncol 2004; 15: 85862.
  • 11
    KleberM,CybullaM,BauchmüllerK,IhorstG,KochB,EngelhardtM. Monitoring of renal function in cancer patients: an ongoing challenge for clinical practice. Ann Oncol 2007; 18: 9508.
  • 12
    KaushalR,ShojaniaKG,BatesDW. Effects of computerized physician order entry and clinical decision support systems on medication safety: asystematic reviw. Arch Intern Med 2003; 163: 140916.
  • 13
    BatesDW,LeapeLL,CullenDJ,LairdN,PetersenLA,TeichJM,BurdickE,HickeyM,KleefieldS,SheaB,Vander VlietM,SegerDL. Effect of computerized physician order entry and team intervention on prevention of serious medication errors. JAMA 1998; 280: 131116.
  • 14
    GandhiTK,WeingartSN,SeqerAC. Outpatient prescribing errors and the impact of computerized prescribing. J Gen Intern Med 2005; 20: 83741.
  • 15
    KupermanGJ,TeichJM,GandhiTK,BatesDW. Patient safety and computerized medication ordering at Brigham and Women's Hospital. Jt Comm J Qual Improv 2001; 27: 50921.
  • 16
    BatesDW,BoyleDL,Vander VlietMB,SchneiderJ,LeapeL. Relationship between medication errors and adverse drug events. J Gen Intern Med 1995; 10: 199205.
  • 17
    LesarTS,BricelandL,SteinDS. Factors related to errors in medication prescribing. JAMA 1997; 277: 31217.
  • 18
    ConnorM,ConnorM,PontePR,ConwayJ. Multidisciplinary approaches to reducing error and risk in a patient care setting. Crit Care Nurs Clin North Am 1995; 14: 35967.
  • 19
    FischerDS,AlfanoS,KnobfMT,DonovanC,BeaulieuN. Improving the cancer chemotherapy use process. J Clin Oncol 1996; 14: 314855.
  • 20
    FolliHL,PooleRL,BenitzWE,RussoJC. Medication error prevention by clinical pharmacists in two children's hospitals. Pediatrics 1987; 79: 71822.
  • 21
    CalvertAH,NewellDR,GumbrellLA. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989; 7: 174856.
  • 22
    KaushalR,BatesDW,LandriganC. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001; 285: 211420.